Literature DB >> 11733767

CHK2 kinase--a busy messenger.

J Bartek1, J Falck, J Lukas.   

Abstract

Checkpoint kinase 2 (Chk2) is emerging as a key mediator of diverse cellular responses to genotoxic stress, guarding the integrity of the genome throughout eukaryotic evolution. Recent studies show the fundamental role of Chk2 in the network of genome-surveillance pathways that coordinate cell-cycle progression with DNA repair and cell survival or death. Defects in Chk2 contribute to the development of both hereditary and sporadic human cancers, and earmark this kinase as a candidate tumour suppressor and an attractive target for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733767     DOI: 10.1038/35103059

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  114 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity.

Authors:  Siyuan Tan; Dmitry Guschin; Albert Davalos; Ya-Li Lee; Andrew W Snowden; Yann Jouvenot; H Steven Zhang; Katherine Howes; Andrew R McNamara; Albert Lai; Chris Ullman; Lindsey Reynolds; Michael Moore; Mark Isalan; Lutz-Peter Berg; Bradley Campos; Hong Qi; S Kaye Spratt; Casey C Case; Carl O Pabo; Judith Campisi; Philip D Gregory
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-26       Impact factor: 11.205

3.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Authors:  Pia Vahteristo; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Salla Ojala; Outi Kilpivaara; Anitta Tamminen; Juha Kononen; Kristiina Aittomäki; Päivi Heikkilä; Kaija Holli; Carl Blomqvist; Jiri Bartek; Olli-P Kallioniemi; Heli Nevanlinna
Journal:  Am J Hum Genet       Date:  2002-07-28       Impact factor: 11.025

4.  Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.

Authors:  Hiroyuki Takai; Kazuhito Naka; Yuki Okada; Miho Watanabe; Naoki Harada; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Makoto Nakanishi; Hiroshi Suzuki; Kazuo Nagashima; Hirofumi Sawa; Kyoji Ikeda; Noboru Motoyama
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

5.  DNA damage checkpoint kinase Chk2 triggers replicative senescence.

Authors:  Véronique Gire; Pierre Roux; David Wynford-Thomas; Jean-Marc Brondello; Vjekoslav Dulic
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

6.  Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation.

Authors:  Yiling Hong; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

7.  Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.

Authors:  Venkateswara Rao Gogineni; Arun Kumar Nalla; Reshu Gupta; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Cancer Lett       Date:  2011-09-06       Impact factor: 8.679

8.  Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.

Authors:  Yaron Pereg; Suzanne Lam; Amina Teunisse; Sharon Biton; Erik Meulmeester; Leonid Mittelman; Giacomo Buscemi; Koji Okamoto; Yoichi Taya; Yosef Shiloh; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.

Authors:  Antony W Oliver; Angela Paul; Katherine J Boxall; S Elaine Barrie; G Wynne Aherne; Michelle D Garrett; Sibylle Mittnacht; Laurence H Pearl
Journal:  EMBO J       Date:  2006-06-22       Impact factor: 11.598

10.  p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.

Authors:  Irene M Ward; Kay Minn; Jan van Deursen; Junjie Chen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.